Trial
NCT04746495
Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Hypertension
Intervention
Placebo
Why stopped
Issues relate to COVID-19 and staffing challenges, as well as very tight finances.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-21